<SEC-DOCUMENT>0001974494-26-000023.txt : 20260107
<SEC-HEADER>0001974494-26-000023.hdr.sgml : 20260107
<ACCEPTANCE-DATETIME>20260107131959
ACCESSION NUMBER:		0001974494-26-000023
CONFORMED SUBMISSION TYPE:	144
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20260107
DATE AS OF CHANGE:		20260107

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NewAmsterdam Pharma Co N.V.
		CENTRAL INDEX KEY:			0001936258
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				000000000
		STATE OF INCORPORATION:			P7
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		144
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	001-41562
		FILM NUMBER:		26514976

	BUSINESS ADDRESS:	
		STREET 1:		GOOIMEER 2-35
		CITY:			NARRDEN
		STATE:			P7
		ZIP:			1411 DC
		BUSINESS PHONE:		35 206 2971

	MAIL ADDRESS:	
		STREET 1:		GOOIMEER 2-35
		CITY:			NARRDEN
		STATE:			P7
		ZIP:			1411 DC

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NewAmsterdam Pharma Co B.V.
		DATE OF NAME CHANGE:	20220701

REPORTING-OWNER:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Davidson Michael H.
		CENTRAL INDEX KEY:			0001573785
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		144

	MAIL ADDRESS:	
		STREET 1:		C/O BIOAGE LABS, INC.
		STREET 2:		5885 HOLLIS STREET, SUITE 370
		CITY:			EMERYVILLE
		STATE:			CA
		ZIP:			94608
</SEC-HEADER>
<DOCUMENT>
<TYPE>144
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common">
  <!-- Generated by Workiva -->
  <headerData>
    <submissionType>144</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <cik>0001573785</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>



    </filerInfo>
  </headerData>
  <formData>
    <issuerInfo>
      <issuerCik>0001936258</issuerCik>
      <issuerName>NewAmsterdam Pharma Co. N.V.</issuerName>
      <secFileNumber>001-41562</secFileNumber>
      <issuerAddress>
        <com:street1>2-35 Naarden</com:street1>
        <com:city>NETHERLANDS</com:city>
        <com:stateOrCountry>P7</com:stateOrCountry>
        <com:zipCode>1411 DC</com:zipCode>
      </issuerAddress>
      <issuerContactPhone>310352062971</issuerContactPhone>
      <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>Michael Davidson</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
      <relationshipsToIssuer>
        <relationshipToIssuer>affiliate</relationshipToIssuer>
      </relationshipsToIssuer>
    </issuerInfo>
    <securitiesInformation>
      <securitiesClassTitle>Ordinary Shares</securitiesClassTitle>
      <brokerOrMarketmakerDetails>
        <name>J.P. Morgan Securities LLC</name>
        <address>
          <com:street1>270 Park Ave</com:street1>
          <com:street2>10th Floor</com:street2>
          <com:city>New York</com:city>
          <com:stateOrCountry>NY</com:stateOrCountry>
          <com:zipCode>10017</com:zipCode>
        </address>
      </brokerOrMarketmakerDetails>
      <noOfUnitsSold>11582</noOfUnitsSold>
      <aggregateMarketValue>410888.61</aggregateMarketValue>
      <noOfUnitsOutstanding>113390000</noOfUnitsOutstanding>
      <approxSaleDate>01/07/2026</approxSaleDate>
      <securitiesExchangeName>NASDAQ</securitiesExchangeName>
    </securitiesInformation>
    <securitiesToBeSold>
      <securitiesClassTitle>Ordinary Shares</securitiesClassTitle>
      <acquiredDate>01/06/2026</acquiredDate>
      <natureOfAcquisitionTransaction>Vesting of RSU Grant</natureOfAcquisitionTransaction>
      <nameOfPersonfromWhomAcquired>NewAmsterdam Pharma Company N.V. (issuer)</nameOfPersonfromWhomAcquired>
      <isGiftTransaction>N</isGiftTransaction>
      <amountOfSecuritiesAcquired>41177</amountOfSecuritiesAcquired>
      <paymentDate>01/06/2026</paymentDate>
      <natureOfPayment>RSU Vesting</natureOfPayment>
    </securitiesToBeSold>
    <nothingToReportFlagOnSecuritiesSoldInPast3Months>Y</nothingToReportFlagOnSecuritiesSoldInPast3Months>
    <noticeSignature>
      <noticeDate>01/07/2026</noticeDate>
      <signature>J.P. Morgan Securities LLC, Workplace Solutions, as Agent and Attorney in Fact for Michael Davidson , NewAmsterdam Pharma Co. N.V.</signature>
    </noticeSignature>
  </formData>
</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
